John Fisher M.D. is the CEO of Biopsy Sciences. He received his training in Interventional Radiology at the Massachusetts General Hospital, Harvard Medical School, in 1990. Dr. Fisher is the founder of Biopsy Sciences and as CEO has successively navigated the company from a startup founded in 2000 to a multi-product acquisition by Angiotech Pharmaceuticals in January of 2007. Dr. Fisher holds over 25 U.S. and EU patents and patent applications. He received his B.A. degree in Chemistry from Southern Methodist University in 1981 and graduated AOA from the University of Kansas Medical School in 1985 and completed his Radiology Residency at the University of Kansas in 1989.

Fred Ahari is founder and Chief Technology Officer of Biopsy Sciences. A highly successful medical device entrepreneur, Fred has founded 2 medical device companies and held senior technical positions in both large and small size medical device corporations. Fred is either author or co-author on over 20 issued and filed patent applications involving novel and unique technologies in medical device applications. His technical skills, management skills, and leadership have been instrumental in successfully introducing novel technologies in medical devices. He held a senior technical position with Datascope Corporation before founding Biopsy Sciences. Fred has a B.S. degree in Mechanical Engineering, and a Master of Science degree in Mechanical Engineering from Northeastern University.

Mr. Gibson is a founder of Biopsy Sciences responsible for legal, accounting, insurance and tax matters. He graduated from Kettering University (FKA General Motors Institute) with a Bachelors degree in Mechanical Engineering and pursued an MBA at Butler University. He founded Gibson - Lewis Companies, a commercial contractor, which was sold in 1995 after growing to an annual volume of $250 million. He then founded Southeast Retirement Corp. to develop and manage retirement homes and ALF's in Florida which were subsequently sold to Goldman Sachs. Mr. Gibson also has general partnership interests in various real estate development projects.